Header cover image

Belgian Pharmaceuticals & Biotech Sustainable Track Record

Results

1

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

argenx

Market Cap: €46.6b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€781.80

7D

2.5%

1Y

63.5%